May 08, 2017 - M&A and licensing deals as well as drug pricing issues are expected to remain in focus in 2017.
May 08, 2017 - Top Research Reports for Today: UTX, LLY & AXP
May 08, 2017 - Major pharma companies like Pfizer (PFE) and Merck reported Q1 results last week.
Apr 26, 2017 - Companies in the News are:
Apr 26, 2017 - Eli Lilly & Co. (NYSE:LLY)Q1 2017 Earnings CallApril 25, 2017 9:00 am ETExecutivesDavid A. Ricks - Eli Lilly & Co.Philip Johnson - Eli Lilly & Co.Derica W. Rice - Eli Lilly & Co.Susan Mahony - Eli Lil
Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.
Apr 25, 2017 - Apart from the usual earnings and revenue numbers, investors will be focused on the performance of Celgene's (CELG) key products and its pipeline progress.
Apr 25, 2017 - Valeant is undercutting Novartis and Lilly with its pricing of psoriasis drug Siliq. How much will the strategy help?
Apr 25, 2017 - Names on the move ahead of the open.
Apr 25, 2017 - Eli Lilly and Company (LLY) reported first-quarter 2017 adjusted earnings per share of 98 cents, which beat the Zacks Consensus Estimate of 96 cents by 2.1%.